Regulus Therapeutics Statistics

Total Valuation

RGLS has a market cap or net worth of $115.22 million. The enterprise value is $19.01 million.

Market Cap	115.22M
Enterprise Value	19.01M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, after market close.

Earnings Date	Aug 6, 2024
Ex-Dividend Date	n/a

Share Statistics

RGLS has 65.47 million shares outstanding. The number of shares has increased by 70.66% in one year.

Shares Outstanding	65.47M
Shares Change (YoY)	+70.66%
Shares Change (QoQ)	+42.06%
Owned by Insiders (%)	1.68%
Owned by Institutions (%)	90.81%
Float	42.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.07
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.85, with a Debt / Equity ratio of 0.01.

Current Ratio	17.85
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-61.73

Financial Efficiency

Return on equity (ROE) is -65.70% and return on invested capital (ROIC) is -29.88%.

Return on Equity (ROE)	-65.70%
Return on Assets (ROA)	-55.40%
Return on Capital (ROIC)	-29.88%
Revenue Per Employee	n/a
Profits Per Employee	-$1.12M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, RGLS has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.33% in the last 52 weeks. The beta is 1.64, so RGLS's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	+17.33%
50-Day Moving Average	2.22
200-Day Moving Average	1.74
Relative Strength Index (RSI)	35.37
Average Volume (20 Days)	1,688,275

Short Selling Information

The latest short interest is 3.58 million, so 5.46% of the outstanding shares have been sold short.

Short Interest	3.58M
Short Previous Month	2.59M
Short % of Shares Out	5.46%
Short % of Float	8.32%
Short Ratio (days to cover)	8.30

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-32.57M
Pretax Income	-31.37M
Net Income	-31.37M
EBITDA	-30.61M
EBIT	-30.87M
Earnings Per Share (EPS)	-$1.45

Full Income Statement

Balance Sheet

The company has $97.62 million in cash and $1.41 million in debt, giving a net cash position of $96.21 million or $1.47 per share.

Cash & Cash Equivalents	97.62M
Total Debt	1.41M
Net Cash	96.21M
Net Cash Per Share	$1.47
Equity (Book Value)	107.59M
Book Value Per Share	1.64
Working Capital	95.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.40 million and capital expenditures -$838,000, giving a free cash flow of -$28.23 million.

Operating Cash Flow	-27.40M
Capital Expenditures	-838,000
Free Cash Flow	-28.23M
FCF Per Share	-$0.98

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RGLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-70.66%
Shareholder Yield	-70.66%
Earnings Yield	-27.22%
FCF Yield	-24.50%

Analyst Forecast

The average price target for RGLS is $11.00, which is 525.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.00
Price Target Difference	525.00%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 29, 2022. It was a reverse split with a ratio of 1:10.

Last Split Date	Jun 29, 2022
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	3